-
SynthRAD2025 Grand Challenge dataset: generating synthetic CTs for radiotherapy
Authors:
Adrian Thummerer,
Erik van der Bijl,
Arthur Jr Galapon,
Florian Kamp,
Mark Savenije,
Christina Muijs,
Shafak Aluwini,
Roel J. H. M. Steenbakkers,
Stephanie Beuel,
Martijn P. W. Intven,
Johannes A. Langendijk,
Stefan Both,
Stefanie Corradini,
Viktor Rogowski,
Maarten Terpstra,
Niklas Wahl,
Christopher Kurz,
Guillaume Landry,
Matteo Maspero
Abstract:
Medical imaging is essential in modern radiotherapy, supporting diagnosis, treatment planning, and monitoring. Synthetic imaging, particularly synthetic computed tomography (sCT), is gaining traction in radiotherapy. The SynthRAD2025 dataset and Grand Challenge promote advancements in sCT generation by providing a benchmarking platform for algorithms using cone-beam CT (CBCT) and magnetic resonanc…
▽ More
Medical imaging is essential in modern radiotherapy, supporting diagnosis, treatment planning, and monitoring. Synthetic imaging, particularly synthetic computed tomography (sCT), is gaining traction in radiotherapy. The SynthRAD2025 dataset and Grand Challenge promote advancements in sCT generation by providing a benchmarking platform for algorithms using cone-beam CT (CBCT) and magnetic resonance imaging (MRI).
The dataset includes 2362 cases: 890 MRI-CT and 1472 CBCT-CT pairs from head-and-neck, thoracic, and abdominal cancer patients treated at five European university medical centers (UMC Groningen, UMC Utrecht, Radboud UMC, LMU University Hospital Munich, and University Hospital of Cologne). Data were acquired with diverse scanners and protocols. Pre-processing, including rigid and deformable image registration, ensures high-quality, modality-aligned images. Extensive quality assurance validates image consistency and usability.
All imaging data is provided in MetaImage (.mha) format, ensuring compatibility with medical image processing tools. Metadata, including acquisition parameters and registration details, is available in structured CSV files. To maintain dataset integrity, SynthRAD2025 is divided into training (65%), validation (10%), and test (25%) sets. The dataset is accessible at https://doi.org/10.5281/zenodo.14918089 under the SynthRAD2025 collection.
This dataset supports benchmarking and the development of synthetic imaging techniques for radiotherapy applications. Use cases include sCT generation for MRI-only and MR-guided photon/proton therapy, CBCT-based dose calculations, and adaptive radiotherapy workflows. By integrating diverse acquisition settings, SynthRAD2025 fosters robust, generalizable image synthesis algorithms, advancing personalized cancer care and adaptive radiotherapy.
△ Less
Submitted 24 February, 2025;
originally announced February 2025.
-
SynthRAD2023 Grand Challenge dataset: generating synthetic CT for radiotherapy
Authors:
Adrian Thummerer,
Erik van der Bijl,
Arthur Jr Galapon,
Joost JC Verhoeff,
Johannes A Langendijk,
Stefan Both,
Cornelis,
AT van den Berg,
Matteo Maspero
Abstract:
Purpose: Medical imaging has become increasingly important in diagnosing and treating oncological patients, particularly in radiotherapy. Recent advances in synthetic computed tomography (sCT) generation have increased interest in public challenges to provide data and evaluation metrics for comparing different approaches openly. This paper describes a dataset of brain and pelvis computed tomograph…
▽ More
Purpose: Medical imaging has become increasingly important in diagnosing and treating oncological patients, particularly in radiotherapy. Recent advances in synthetic computed tomography (sCT) generation have increased interest in public challenges to provide data and evaluation metrics for comparing different approaches openly. This paper describes a dataset of brain and pelvis computed tomography (CT) images with rigidly registered CBCT and MRI images to facilitate the development and evaluation of sCT generation for radiotherapy planning.
Acquisition and validation methods: The dataset consists of CT, CBCT, and MRI of 540 brains and 540 pelvic radiotherapy patients from three Dutch university medical centers. Subjects' ages ranged from 3 to 93 years, with a mean age of 60. Various scanner models and acquisition settings were used across patients from the three data-providing centers. Details are available in CSV files provided with the datasets.
Data format and usage notes: The data is available on Zenodo (https://doi.org/10.5281/zenodo.7260705) under the SynthRAD2023 collection. The images for each subject are available in nifti format.
Potential applications: This dataset will enable the evaluation and development of image synthesis algorithms for radiotherapy purposes on a realistic multi-center dataset with varying acquisition protocols. Synthetic CT generation has numerous applications in radiation therapy, including diagnosis, treatment planning, treatment monitoring, and surgical planning.
△ Less
Submitted 28 March, 2023;
originally announced March 2023.
-
Mapping the Future of Particle Radiobiology in Europe: The INSPIRE Project
Authors:
N. T. Henthorn,
O. Sokol,
M. Durante,
L. De Marzi,
F. Pouzoulet,
J. Miszczyk,
P. Olko,
S. Brandenburg,
M-J. van Goethem,
L. Barazzuol,
M. Tambas,
J. A. Langendijk,
M. Davidkova,
V. Vondravcek,
E. Bodenstein,
J. Pawelke,
A. Lomax,
D. C. Weber,
A. Dasu,
B. Stenerlow,
P. R. Poulsen,
B. S. Sorensen,
C. Grau,
M. K. Sitarz,
A-C Heuskin
, et al. (5 additional authors not shown)
Abstract:
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a number of unanswered questions considering differences in the biological response between particles and photons. These questions, and probing of biological mechanisms in general, necessitate experimental investigation. The Infrastructure in Proton International Research (INSPIRE) project was created t…
▽ More
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a number of unanswered questions considering differences in the biological response between particles and photons. These questions, and probing of biological mechanisms in general, necessitate experimental investigation. The Infrastructure in Proton International Research (INSPIRE) project was created to provide an infrastructure for European research, unify research efforts on the topic of proton and ion therapy across Europe, and to facilitate the sharing of information and resources. This work highlights the radiobiological capabilities of the INSPIRE partners, providing details of physics (available particle types and energies), biology (sample preparation and post-irradiation analysis), and researcher access (the process of applying for beam time). The collection of information reported here is designed to provide researchers both in Europe and worldwide with the tools required to select the optimal center for their research needs. We also highlight areas of redundancy in capabilities and suggest areas for future investment.
△ Less
Submitted 7 July, 2020;
originally announced July 2020.
